AIM ImmunoTech CEO to Participate in Virtual Panel Presentation at the 23rd Annual BioFlorida Conference on October 29th
AIM ImmunoTech Inc. (NYSE American: AIM) announced that CEO Thomas K. Equels will participate in a virtual panel titled “COVID-19: Progress on Treatments & Prevention” on October 29 at 10:05 A.M. ET during the 23rd Annual BioFlorida Conference. The conference will feature discussions by global experts on BioPharma, MedTech, HealthIT, and COVID-19. Attendees can access the live webcast via the conference platform. AIM ImmunoTech is dedicated to developing therapeutics for cancers, immune disorders, and viral diseases, including COVID-19.
- None.
- None.
OCALA, Fla. , Oct. 22, 2020 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) today announced that Thomas K. Equels, Chief Executive Officer of AIM ImmunoTech, is scheduled to participate in a virtual panel titled, “COVID-19: Progress on Treatments & Prevention” on Thursday, October 29, at 10:05 A.M. Eastern Time at the 23rd Annual BioFlorida Conference. The presentation will be webcast live on the conference event platform, which can be accessed here.
The BioFlorida Conference 2020 will feature global experts in keynote and breakout sessions addressing the latest trends in BioPharma, MedTech, HealthIT and COVID-19. Informative programs will cover current science advancements, business and public policy, as well as showcase Florida’s achievements and innovation.
About AIM ImmunoTech Inc.
AIM ImmunoTech Inc. is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and viral diseases, including COVID-19, the disease caused by the SARS-CoV-2 virus. For more information on AIM ImmunoTech, please visit www.aimimmuno.com.
Contacts:
Crescendo Communications, LLC
Phone: 212-671-1021
Email: aim@crescendo-ir.com
AIM ImmunoTech Inc
Phone: 800-778-4042
Email: IR@aimimmuno.com
FAQ
What is the date and time of the AIM ImmunoTech panel at the BioFlorida Conference?
Where can I watch the AIM ImmunoTech conference panel?
What topics will be discussed at the BioFlorida Conference 2020?
What is AIM ImmunoTech's focus in terms of therapeutics?